Non-reinforced retrieval induces memory extinction, a phenomenon characterized by a decrease in the intensity of the learned response. This attribute has been used to develop extinction-based therapies to treat anxiety and post-traumatic stress disorders. Histamine modulates memory and anxiety but its role on fear extinction has not yet been evaluated. Therefore, using male Wistar rats, we determined the effect of the intra-hippocampal administration of different histaminergic agents on the extinction of step-down inhibitory avoidance (IA), a form of aversive learning. We found that intra-CA1 infusion of histamine immediately after non-reinforced retrieval facilitated consolidation of IA extinction in a dose-dependent manner. This facilitation was mimicked by the histamine N-methyltransferase inhibitor SKF91488 and the H 2 receptor agonist dimaprit, reversed by the H 2 receptor antagonist ranitidine, and unaffected by the H 1 antagonist pyrilamine, the H 3 antagonist thioperamide and the antagonist at the NMDA receptor (NMDAR) polyamine-binding site ifenprodil. Neither the H 1 agonist 2-2-pyridylethylamine nor the NMDAR polyamine-binding site agonist spermidine affected the consolidation of extinction while the H 3 receptor agonist imetit hampered it. Extinction induced the phosphorylation of ERK1 in dorsal CA1 while intra-CA1 infusion of the MEK inhibitor U0126 blocked extinction of the avoidance response. The extinction-induced phosphorylation of ERK1 was enhanced by histamine and dimaprit and blocked by ranitidine administered to dorsal CA1 after non-reinforced retrieval. Taken together, our data indicate that the hippocampal histaminergic system modulates the consolidation of fear extinction through a mechanism involving the H 2 -dependent activation of ERK signalling.
Introduction
Non-reinforced expression of conditioned fear leads to extinction of the learned response. This property has been used to develop extinction-based therapies to treat anxiety disorders. Nevertheless, although these therapies are effective, relapse following their apparent success is frequent (Rowe & Craske, 1998) . Since extinction results from a new learning that inhibits the original memory (Pavlov, 1928) , it is possible that treatments that facilitate memory formation also improve the therapeutic effectiveness of extinction (Davis et al. 2006) .
Histamine is synthesized by neurons in the tuberomammilary nucleus which ramify throughout the brain. Of the four histamine receptors identified so far only H 1 , H 2 and H 3 subtypes are expressed in the brain. H 1 and H 2 receptors potentiate excitatory inputs while H 3 receptors down-regulate histamine synthesis and release as well as release of other neurotransmitters (Haas & Panula, 2003 ; Panula et al. 1989) . Histamine controls the sleep-wake cycle and nociception and modulates the activity of the hippocampus, a brain region essential for aversive memory processing (Brown et al. 2001) . In fact, hippocampal histamine receptors are involved in fear memory consolidation and control anxiety (Da Silva et al. 2006 ; Passani et al. 2007 ; Zarrindast et al. 2002) . However, the role of histamine in the consolidation of extinction memory has not yet been analysed.
Here, we determined the effect of the intra-CA1 infusion of different histaminergic agents on the extinction of step-down inhibitory avoidance (IA), a well-established model for studying fear memory in the rat. Because histamine modulates ERK1/2 signalling (Passani et al. 2007) , and these kinases are necessary for extinction (Herry et al. 2006 ), we also analysed the possible interplay between histamine and ERK activation.
Materials and methods

Subjects, surgery and infusion procedures
Male Wistar rats, aged 3 months (280-300 g) were used. They were housed at 22-24 xC and maintained on a 12-h light/dark cycle (lights on 07 : 00 hours) with free access to food and water. Rats were bilaterally implanted with 27-gauge stainless-steel cannulas in the CA1 region of the dorsal hippocampus under ketamine/xylazineanaesthesia.Stereotaxiccoordinates were 4.0 mm posterior to bregma, 3.0 mm lateral to the midline, and 1.8 mm ventral to the skull surface (Paxinos & Watson, 1986) . Infusions (1 ml/side) were carried out using an infusion pump. Placement of the cannulas was verified post-mortem : 2-4 h after the last behavioural test, 1 ml of a 4 % Methylene Blue solution was infused as described above and the extension of the dye 30 min thereafter taken as an indication of the diffusion of the drug previously injected. Only data from animals with correct implants were analysed. All experimental procedures followed the guidelines of the USA National Institutes of Health Guide for the Care and Use of Laboratory Animals (DHEW Publications, NIH 80-23) and were approved by the Animal Care and Use Committees of the Pontifical Catholic University of Rio Grande do Sul.
IA training and extinction
The training apparatus was a 50r25r25 cm poly-(methyl methacrylate) box with a 5-cm high, 8-cm wide and 25-cm long platform on the left end of a grid of bronze bars. During the training session the animals were placed on the platform and when they stepped down onto the grid, received a 2-s, 0.8-mA scrambled footshock. To extinguish the avoidance response, rats were submitted to one non-reinforced IA test session 24 h or 72 h post-training. To achieve this, the animals were placed on the training box platform until they stepped down onto the grid. No footshock was given and the animals were allowed to explore the apparatus for 10 min. During this time, they stepped up onto the platform and down again several times. Retention was assessed in a second non-reinforced test session 24 h or 72 h later.
Open-field and plus-maze tests
To analyse their locomotor and exploratory activities, animals were placed in a 50r50r39 cm open-field arena with the floor divided into 12 equal squares. Line crossings and rearings were measured over a 5-min period. To evaluate their anxiety state, rats were exposed to an elevated plus-maze exactly as described by Pellow et al. (1985) . The total number of entries into the four arms and the number of entries and time spent into the open arms were recorded over a 5-min session.
Immunoblot
Animals were killed by decapitation and the CA1 region of the dorsal hippocampus homogenized in ice-chilled buffer [20 mM Tris-HCl (pH 7.4), 0.32 M sucrose, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 10 mg/ml aprotinin, 15 mg/ml leupeptin, 10 mg/ml bacitracin, 10 mg/ml pepstatin, 15 mg/ml trypsin inhibitor, 50 mM NaF, and 1 mM sodium orthovanadate]. Equal amounts of protein were fractionated by SDS-PAGE and electrotransferred to PVDF membranes. Blots were blocked in 100 mm Tris-HCl (pH 7.5), containing 0.9 % NaCl and 0.1 % Tween-20 and incubated overnight with anti-ERK1/2 or antiphosphoERK1/2 antibodies. Immunoreactivity was quantified using the West-Pico enhanced chemiluminescence kit (Pierce, USA) and the ImageQuant RT-ECL system (GE, USA).
Drugs and antibodies
Drugs were from Sigma-Aldrich (USA), Tocris Cookson Ltd (UK) or Promega (USA). Antibodies were from Cell Signaling (USA). Drugs were dissolved in saline or DMSO and stored at x20 xC. Before use aliquots were diluted to working concentration with vehicle (0.1 % DMSO in saline ; pH 7.2). The doses used were based on pilot experiments and on studies showing their effect on behavioural and physiological variables (Alvarez & Ruarte, 2002 ; Baldi et al. 2005 ; Di Carlo et al. 2000 ; Duch et al. 1978 ; Giovannini et al. 2003 ; Knoche et al. 2003 ; Malmberg-Aiello et al. 1997) .
Statistical analyses
Data were analysed by Student's t test or one-way ANOVA followed by Dunnett's test.
Results
To analyse the role of the hippocampal histaminergic system in the consolidation of fear extinction, rats received IA training and 24 h later were submitted to a 10-min non-reinforced test session to extinguish the avoidance response. At different times after this session, the animals received bilateral intra-CA1 infusions of vehicle, histamine (0.1-10 nmol/side) or SKF91488 (0.5-50 nmol/side), a histamine N-methyltransferase inhibitor which blocks histamine inactivation (Malmberg-Aiello et al. 1997) . Extinction was assessed 24 h later. When administered immediately after non-reinforced retrieval, histamine ( Fig. 1a ; F 3,78 =3.97, p<0.05 ; q=3.02 for 10 nmol/side) and SKF91488 ( Fig. 1b ; F 3,96 =3.22, p<0.05 ; q=2.98 for 50 nmol/side) facilitated the consolidation of extinction in a dose-dependent manner. Histamine and SKF91488 had no effect on the consolidation of extinction when administered 90 min after the nonreinforced test (Fig. 1c) and did not affect IA memory when administered 24 h post-training in the absence of a non-reinforced retention test session (Fig. 1d) . The effect of histamine and SKF91488 on the consolidation of extinction was also observed when retention was assessed 72 h after the non-reinforced test (Fig. 1e ). Retention was evaluated 72 h after RT1 (RT2). (f) Animals were treated as in (a) and received infusions of His (10 nmol/side) or SKF (50 nmol/side) immediately after RT1. Retention was evaluated 24 h later (RT2). Immediately after stepping-down onto the grid during RT2, rats received a footshock identical to that received during the training session. Retention was re-evaluated 24 h later (RT3). Bars represent mean (¡S.E.M.) ; n=16-25 per group ; * p<0.05 and ** p<0.01 in Dunnett's test after ANOVA.
Intra-CA1 administration of histamine and SKF91488 immediately after non-reinforced retrieval did not affect reacquisition of IA memory upon retraining ( Fig. 1f ; F 2,44 =0.56, p=0.57). H 1 , H 2 and H 3 receptors are expressed in the hippocampus. Moreover, histamine binds to the polyamine site of the N-methyl-D-aspartate receptor (NMDAR ; Haas & Panula, 2003) . Since activation of different histamine receptor subtypes induces opposite physiological responses (Baldi et al. 2005) and polyamines modulate fear conditioning (Camera et al. 2007) , we studied the specific participation of H 1 , H 2 and H 3 receptors and of the NMDAR polyamine site in extinction.
When administered to dorsal CA1 immediately after non-reinforced retrieval the H 2 agonist dimaprit (10 nmol/side), but not the H 1 agonist 2-2-pyridylethylamine (2-PEA ; 10 nmol/side ; Braga et al. 1996) or the agonist at NMDAR polyamine-binding site, spermidine (10 nmol/side ; Berlese et al. 2005) , mimicked the facilitation induced by histamine (Fig. 2) . Concurring with the putative role of H 3 receptors as negative regulators of histamine synthesis and release, the H 3 receptor agonist imetit (10 nmol/side) hampered the consolidation of extinction memory, suggesting that endogenous histamine modulates this process, possibly through activation of hippocampal H 2 receptors (F 4,95 =9.39, p<0.001 ; q=2.70 for dimaprit and q=3.39 for imetit). In order to analyse this hypothesis, we studied the effect of specific antagonists of histamine receptor subtypes on extinction. When administered to dorsal CA1 immediately after non-reinforced retrieval, the H 2 antagonist ranitidine (50 nmol/side), but not the H 1 antagonist pyrilamine (50 nmol/side), the H 3 antagonist thioperamide (50 nmol/side) or the NMDAR polyamine-binding site antagonist ifenprodil (50 nmol/side ; Sotres-Bayon et al. 2009) blocked extinction ( Fig. 3a ; F 4 ,95 =3.23, p<0.05 ; q=2.83 for ranitidine). Co-infusion of ranitidine, but not pyrilamine, thioperamide or ifenprodil, abolished the facilitation induced by histamine ( Fig. 3b ; F 4 ,95 =19.45, p<0.001 ; q=7.37 for ranitidine). Ranitidine, dimaprit and imetit did not affect IA memory when administered to dorsal CA1 24 h posttraining in the absence of a non-reinforced retention test session (Fig. 3c) . None of these compounds, nor histamine or SKF91488, modified the animals ' performance in the open field or in the elevated plusmaze when administered to dorsal CA1 24 h prior to the respective behavioural sessions (Table 1) .
Histamine regulates ERK signalling (Passani et al. 2007 ). Thus, we investigated the modulation of ERK phosphorylation by histamine during the consolidation of extinction. Intra-CA1 infusion of the MEK1/2 inhibitor U0126 (2 pmol/side) immediately after non-reinforced retrieval blocked extinction ( Fig. 4a ; t 38 =3.38, p<0.01), which was accompanied by an increase in the phosphorylation state of ERK1, peaking 120 min after retrieval ( Fig. 4b ; F 3 ,20 =8.24, p<0.001 ; q=4.25 for 120 min). This increase was enhanced further by histamine and dimaprit and reduced by ranitidine administered to dorsal CA1 immediately after non-reinforced retrieval ( Fig. 4c ; F 3,20 =22.64, p<0.001 ; q=2.59 for histamine, q=4.83 for dimaprit, q=2.97 for ranitidine). Ranitidine did not affect basal ERK1/2 phosphorylation (Fig. 4d) .
Discussion
The behavioural outcome of histamine administration is not easy to predict because different histamine receptor subtypes induce opposite biochemical effects. Indeed, reports regarding the role of histamine on learning are controversial. While earlier work indicates that histamine improves memory, recent findings suggest that it hinders or has no effect on retention (Alvarez et al. 2001 ; De Almeida & Izquierdo, 1986 ; Eidi et al. 2003 ; Klapdor et al. 1994) . Thus, to avoid the drawbacks associated with the use of multiple-trial learning paradigms and systemic administration of drugs, which make it difficult to interpret experiments regarding the role of histamine in memory formation, we evaluated its involvement in the consolidation of extinction memory by using a single-trial extinction protocol and stereotaxically Step-down latency (s) localized microinfusions. We studied the histaminergic system in the hippocampus because this brain region is essential for fear extinction (Quirk & Mueller, 2008) . We found that when administered to dorsal CA1 after non-reinforced retrieval histamine facilitated extinction in a dose-dependent manner, an effect mimicked by increasing endogenous histamine levels through inhibition of histamine N-methyltransferase and by administration of the H 2 receptor agonist dimaprit. This facilitation was long-lasting, blocked by the H 2 receptor antagonist ranitidine, was contingent with the non-reinforced expression of IA memory and only occurred when histamine was infused immediately and not 90 min after the extinction session. This suggests that it was due to a time-and H 2 -receptor-dependent enhancement of extinction memory consolidation and not to a delayed action on retrieval or on locomotor and exploratory activities. This claim is supported by findings showing that histamine did not affect the animals ' performance in the elevated plus-maze and in the open-field tasks when administered 24 h prior to the respective behavioural sessions. Moreover, the fact that histamine enhanced the extinction-induced phosphorylation of ERK1 through a mechanism involving H 2 receptors, suggests that activation of the ERK cascade during the consolidation of extinction is modulated by this imidazolamine.
Our data concur with reports showing the requirement of hippocampal H 2 receptors for consolidation of IA long-term memory (Da Silva et al. 2006) and are in partial agreement with others indicating that intra-CA3 infusions of H 2 and H 3 agonists improve contextual fear memory (Passani et al. 2007) , supporting the hypothesis that consolidation of fear memory and of fear extinction share some basic biochemical mechanisms within the hippocampus. In particular, ERK activity is essential for both processes Maren & Quirk, 2004) . It was postulated that ERK1/2 coordinate responses to extracellular signals during memory consolidation (Sweatt, 2001 ) and, based on findings showing that ERK signalling is triggered by memory retrieval in CA1 neurons only when anticipation of a fearful experience is not fulfilled, it was proposed that these kinases are essential for coupling error prediction to fear attenuation during extinction (Huh et al. 2009 ). Although the absence of a behavioural phenotype in ERK1 null mice suggested that ERK2 is the ERK isoform responsible for memory formation (Selcher et al. 2001) , a recent report regarding extinction in ERK1 mutant mice indicates that pharmacological modulation of this kinase in the IA-trained animals were tested as in (a) but immediately, 30 min or 120 min thereafter were killed by decapitation, and total homogenates from dorsal CA1 immunoblotted with antibodies against ERK1/2 or ERK1/2 when phosphorylated at Thr 202 /Tyr 204 (pERK1/2). IA-trained rats not submitted to the extinction protocol (no extinction) were used as controls. Data are expressed as mean (¡S.E.M.). ** p<0.01 in Dunnett's test after ANOVA ; n=6 per group. (c) Animals were treated as in (b) but immediately after the extinction session received intra-CA1 Veh, histamine (His ; 10 nmol/side), dimaprit (Dim ; 10 nmol/side) or ranitidine (Ran ; 50 nmol/side) and were killed 120 min later. Data are expressed as mean (¡S.E.M.). * p<0.05 and *** p<0.001 in Dunnett's test after ANOVA ; n=6 per group. (d) Rats with infusion cannulas implanted in the CA1 region received infusions of vehicle (Veh) or ranitidine (Ran ; 50 nmol/side) and 120 min thereafter were killed by decapitation. Total homogenates from dorsal CA1 were immunoblotted as in (b) and (c). Data are expressed as mean (¡S.E.M.) ; n=4 per group. hippocampus is a therapeutic option for the treatment of anxiety and depression (Tronson et al. 2008) . Indeed, although typically considered equivalent, ERK1 and ERK2 have different signalling properties (Frémin et al. 2009 ; Krens et al. 2008 ; Lefloch et al. 2008) . Thus, ERK1 controls ERK2 by acting as a partial agonist for MEK binding, and recent work suggests that while the catalytic action of ERK1 is predominantly cytoplasmatic, ERK2 phosphorylates both cytoplasmatic and nuclear targets (Marchi et al. 2008 ; Vantaggiato et al. 2006) . Future research about the extinction-induced phosphorylation of proteins will help to resolve this question. We previously reported that the full NMDAR antagonist AP5 blocks the consolidation of extinction memory (Cammarota et al. 2005) . However, we did not find any effect of the NR2B-containing NMDAR antagonist ifenprodil on this process. This discrepancy could be explained by the different properties conferred on the NMDAR by NR2A and NR2B subunits. For example, NR2A-but not NR2B-containing receptors are necessary for long-term depression and potentiation (Morishita et al. 2007 ; Zhang et al. 2009) , and NR2A but not NR2B is essential for NMDARdependent dendritic protein synthesis (Tran et al. 2007) .
Anti-histamines are frequently prescribed to treat asthma and rhinitis and, although they cause undesirable behavioural side-effects, their consumption is rapidly growing (Banthin & Miller, 2006 ; Bender, 2005 ; Halpert et al. 2002 ; Lieberman, 2009 ; Van Ruitenbeek et al. 2008) . It is known that histamine acts as a danger response signal modulating fear and that lesion of the tuberomammilary nucleus reduces anxiety (Frisch et al. 1998) . However, the potential use of histaminergic agents to treat the behavioural and cognitive disorders at the root of anxiety and posttraumatic stress disorder has barely been studied. In this context, our finding that histamine facilitates the consolidation of fear extinction through a mechanism involving the H 2 receptor-dependent phosphorylation of ERK1 in the hippocampus is relevant.
